fda.gov - website profile

FDA’s Decision to Approve New Treatment for Alzheimer’s ...

Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly, Aduhelm is the first treatment directed at the underlying pathophysiology of Alzheimer’s...